Pharma Interview Questions UK: What Hiring Panels Test For
Eighteen years of sitting on the hiring panel for junior medical writer and pharmacovigilance roles taught me something most interview prep misses. The questions are not testing what candidates think they are. Here is what UK pharma hiring panels actually listen for, the questions that catch out junior candidates, and the discipline that gets you hired.
What the hiring panel is listening for the moment you open
When I am sitting on the other side of the panel, the first thing I am listening for is whether the candidate can give me a clean high-level summary of what they have been doing for the past year or 2 years, however long they have been a medical writer. Not the CV reread. A structured account of their actual scope.
Inside that summary I am tracking five things at once.
Which regulatory authorities they have written for. EMA only, or EMA plus FDA, Health Canada and other authorities. That single piece of information tells me the breadth of their compliance instincts.
Which clinical documents they have actually worked on. Regulatory responses, clinical study reports, module 2 summaries, major global submissions. I am listening for whether they have led major documents or contributed sections to documents led by others. There is a difference.
Their leadership scope. Were they supportive on the document, or contributing, or the named author driving it end to end? Junior writers often blur this distinction. Senior writers are crisp on it because they know it matters.
Whether they have worked in Pharma, CRO or Biotech. These are very different worlds. Pharma has a lot of internal process and is not heavy on client satisfaction because we are the client. CRO has more bureaucracy and a service relationship to manage. Biotech moves fast and lean. The candidate who has only ever worked in one of these sectors is fine. The candidate who cannot explain the difference is the one I worry about.
How they speak. Honestly, this is the giveaway nobody warns candidates about. If you are all over the place in your summary, jumping from one thing to another, confusing me, I am immediately thinking: if you speak like that, do you write that way? It is an awful thing to admit. It is also true. Your verbal structure predicts your written structure to a degree most candidates do not appreciate.
"Tell me about a time you led a project": and why junior candidates fluff it
This is the classic question. It catches more junior candidates out than any other single question on the panel.
The reason it catches them out is not that they cannot think of a project. The reason is that they cannot depict exactly what their role was to ensure leadership of that project. The honest answer for most junior writers is that they supported. They were contributory. They were not the named author at the forefront of the challenge. So when they try to tell the story as if they led it, the structure breaks down, the details get vague, and the storyline becomes "I supported, I supported, I supported."
The other reason this question fails junior candidates is that they have not actually experienced a challenge of the scale the question implies. So they have no story to tell. They invent one. The invention is visible.
A senior medical writer answering the same question sounds completely different. You immediately know they took the lead. They were the go-to person on the project. They took immediate proactive action based on the scenario. They knew how to defuse conflicts between stakeholders. They used specific tactics to resolve the issue swiftly and protect the timeline and the end quality of the document.
The story does not have to have a happy ending. I prefer the tragic ones. The submission that went out incomplete because of a missed deadline. The document that submitted but with critical gaps. The QC that did not happen because there was no time. I want to hear what the lessons learnt were. What could you have done differently? Where did you take accountability? Where was the system failure and where was your personal contribution to that failure?
Candidates often think the panel wants the polished win. The panel wants the failure that was metabolised into a lesson. The polished win is unmemorable. The honest failure with structured reflection is the one that promotes you.
Technical scenarios are pressure tests, not knowledge tests
When a panel asks "what would you do if you discovered a major data discrepancy late in a CSR" or "how would you handle a missed MHRA deadline", they are not testing your knowledge of the regulatory framework. They are testing your pressure points.
Under serious pressure, do you crumble and panic, or do you move into action mode? Are you a vocal person who flags issues immediately, or are you the writer who notices the discrepancy and thinks "that should have been picked up by biostats, not really my job"? Are you a problem solver, or do you delegate the problem upwards?
The right answer demonstrates three things in one breath: that you flag the issue, that you have already started thinking about resolution, and that you understand which functional team members need to be in the conversation immediately.
There is a wrong answer to "data discrepancy late in a CSR" that I hear more often than I should. The wrong answer is "I would escalate it up to management."
What is management going to do? They will panic, and they will then have to speak to biostats anyway. It would be better if you, as the medical writer, reverted directly to biostats and the relevant functional team members. Inform them of the discrepancy. Lay out the impact on the document and the timeline. Suggest new timelines and buffers where needed. Tighten the areas you can tighten. That is the action of a medical writer who understands what their job is.
For a missed MHRA deadline, the answer is similar. Raise it immediately with regulatory affairs and the team. Determine what communication can be sent to MHRA to negotiate a revised submission window.
The pattern is the same in every technical scenario. We are looking for problem solvers, not problem escalators.
The question candidates underestimate the most
"Why pharma? Why this company?" sounds like the easy one. It is not. It is the question candidates most underestimate, and it is one of the strongest signals on the panel.
A strong answer comes from a deep dive. Before the interview, you should know the company's pipeline. The blockbuster drug they already have or the one that, based on the development pipeline, is likely to be their next blockbuster. The phase studies they are running. How late in the regulatory game they are. The study results that look promising. Whether the therapy area touches you for personal reasons. Whether the culture matches the way you want to work.
If their website is drilling about work, work, work, work and there is nothing about work-life balance and they expect weekend submissions, you need to know that. Not because that is necessarily a deal-breaker, but because it tells you whether the company is the right fit for you, for the long run.
I tell my students one thing about this question: research, research, research. Really know the company. So when they ask, you have a bespoke answer, not a generic one. Maybe you are intrigued by their pipeline. Maybe the therapy area touches you personally. Maybe their values align with yours. Maybe their ethos matches the way you want to grow. Whatever it is, it has to be specific and it has to be yours.
A generic "I want to work in pharma because it is regulated and meaningful" tells the panel you have not done the work. A specific answer about their phase 3 oncology readout last quarter and how it intersects with where you want to take your medical writing career tells the panel you understand the role you are interviewing for.
STAR method, with the example that decides who gets hired
For any healthcare professional who has prepared interview content but has never been through a pharma interview, expect scenario-based questions. Expect to be asked how, not what. And use the STAR method.
STAR is not pharma-specific. It is universal across every industry. With every answer:
- S: Situation. What was happening.
- T: Task. What you were responsible for.
- A: Action. What you actually did.
- R: Result. What happened as a result.
It ensures your answer is succinct, structured, and answers the question without rambling. That is exactly how a senior medical writer answers. When a candidate answers in that structure, I know they know what they are doing. Versus a junior who may babble, drift, and not actually answer everything that was asked.
Here is the example that decides who looks senior in interview, and who looks junior.
I assign you a CSR. I let you know the TLFs are missing. I tell you the biostatistician will have them at some point, but cannot yet give a deadline. What do you do?
A junior medical writer typically answers: "I would wait for the TLFs to come through. Then once they come through, I would chase biostats to see when they will arrive. Or I would escalate to management to let them know it is going to impact my timelines."
A senior medical writer answers completely differently:
"I would immediately go back to biostats and ask for a firm deadline on when to expect the final TLFs. In the interim, I would continue drafting my CSR. I would stay on track with my timelines and inform the team that the first draft will be provided, but with placeholders where the TLFs are missing. The placeholders would identify exactly which TLFs are not yet available, what each one would have informed, and the date by which it will be available. By the next draft, assuming biostats has provided the deadline I requested, I can populate those missing sections without impacting my timelines, my draft reviews, or my team's confidence in the document status."
That is STAR. That is what senior medical writing looks like inside one answer. The junior version waits. The senior version moves. The document keeps progressing either way, because the senior writer has structured the unknown into the work, rather than letting the unknown stall the work.
Three things to do before you walk into a pharma interview
If you are preparing for a UK pharma interview, three things matter more than anything else.
One: research the company deeply. Pipeline, lead assets, phase studies, recent regulatory communications, culture, ethos, work-life balance. Have a bespoke answer ready for why this company, not a generic one.
Two: prepare your structured answers using STAR. For every likely scenario question, write out the Situation, Task, Action and Result. Practise saying them aloud until the structure is automatic.
Three: expect scenario-based questions, not theory questions. The panel wants to know what you would do, not what the regulation says. Be ready to be the problem solver in your answers, not the person who escalates the problem upwards.
None of this is exotic. It is the discipline that separates the candidate who gets shortlisted from the candidate who gets hired.
How to prepare for a pharma interview without scripting yourself
The slowest way to learn how to interview for a UK pharma role is to fail several interviews and reflect afterwards. That works. It also costs you 6 to 12 months and the roles you would have got with better preparation.
The faster way is to work through the questions live, with someone who has been on the hiring panel, before you walk into a real interview. Not to memorise answers. To build the judgement that lets you answer naturally under pressure. PharmaLink Mock Interview is a 1:1 session where I take you through the questions a UK pharma hiring panel actually asks, in the order they ask them, with feedback on every answer. The format mirrors what I run when I am on the panel. Most candidates walk out with the scenario answers structured using STAR, the "why this company" answer rebuilt around a specific company they are targeting, and the data-discrepancy answer rewritten so it does not include "escalate to management."
If you are pivoting into pharma from another healthcare profession, FORGE IQ™ is the AI-powered simulation platform that compresses the room-readiness you need to actually be senior-track once you are in the role. Twelve real industry meetings, multi-persona AI counterparts who respond in real time, and a Principal Medical Writer (Dr Elena Rossi) who authors a first-person debrief at the end of every session. The interview gets you the offer. FORGE IQ™ places you inside the scenarios that decide whether you are seen as senior-track once you start.
Either way, the conversation starts with a fit call. I will tell you honestly whether you are ready, where the gaps are, and which programme matches the gap you actually have.
Dorothy Ogwuru is the founder of PharmaLink Academy. She has spent 18 years in pharmacovigilance and regulatory medical writing across Schering-Plough, MSD, Amgen, Takeda, Tillomed (as Global Head of Pharmacovigilance during COVID), Roche, AstraZeneca, GSK as Senior Regulatory Medical Writer, the Novo Nordisk Ozempic submission, and Daiichi Sankyo. She has interviewed and hired junior medical writers across multiple of these organisations.